NL187267C - PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION, AND PROCESS FOR PREPARING AN N-ARYL-N- (4-PIPERIDINYL) ACETAMIDE DERIVATIVE. - Google Patents

PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION, AND PROCESS FOR PREPARING AN N-ARYL-N- (4-PIPERIDINYL) ACETAMIDE DERIVATIVE.

Info

Publication number
NL187267C
NL187267C NLAANVRAGE7610513,A NL7610513A NL187267C NL 187267 C NL187267 C NL 187267C NL 7610513 A NL7610513 A NL 7610513A NL 187267 C NL187267 C NL 187267C
Authority
NL
Netherlands
Prior art keywords
preparing
piperidinyl
aryl
pharmaceutical preparation
acetamide derivative
Prior art date
Application number
NLAANVRAGE7610513,A
Other languages
Dutch (nl)
Other versions
NL187267B (en
NL7610513A (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NL7610513A publication Critical patent/NL7610513A/en
Publication of NL187267B publication Critical patent/NL187267B/en
Application granted granted Critical
Publication of NL187267C publication Critical patent/NL187267C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE7610513,A 1975-09-23 1976-09-22 PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION, AND PROCESS FOR PREPARING AN N-ARYL-N- (4-PIPERIDINYL) ACETAMIDE DERIVATIVE. NL187267C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (3)

Publication Number Publication Date
NL7610513A NL7610513A (en) 1977-03-25
NL187267B NL187267B (en) 1991-03-01
NL187267C true NL187267C (en) 1991-08-01

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7610513,A NL187267C (en) 1975-09-23 1976-09-22 PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION, AND PROCESS FOR PREPARING AN N-ARYL-N- (4-PIPERIDINYL) ACETAMIDE DERIVATIVE.

Country Status (29)

Country Link
JP (1) JPS6016417B2 (en)
AT (1) AT363935B (en)
AU (1) AU510029B2 (en)
BG (1) BG27543A3 (en)
CA (1) CA1068271A (en)
CH (1) CH628623A5 (en)
CS (1) CS222663B2 (en)
DE (1) DE2642856A1 (en)
DK (1) DK150478C (en)
ES (1) ES451768A1 (en)
FI (1) FI61482C (en)
FR (1) FR2325377A1 (en)
GB (1) GB1539473A (en)
GR (1) GR58469B (en)
HU (1) HU172964B (en)
IE (1) IE43802B1 (en)
IL (1) IL50522A (en)
IT (1) IT1073893B (en)
LU (1) LU75837A1 (en)
NL (1) NL187267C (en)
NO (1) NO147672C (en)
NZ (1) NZ181972A (en)
PH (1) PH12497A (en)
PL (2) PL117323B1 (en)
PT (1) PT65631B (en)
RO (1) RO70079A (en)
SE (1) SE427839B (en)
SU (1) SU747424A3 (en)
YU (1) YU39973B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (en) * 1986-05-08 1987-11-13 株式会社ヘキトク Line system for manufacturing smoked roof tile
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Fast Dissociting Dopamine 2 Receptor Antagonists
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Fast Dissociating Dopamine 2 Receptor Antagonists
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Fast -Dissociating Dopamine 2 Receptor Antagonists
RU2480462C2 (en) * 2007-04-23 2013-04-27 Янссен Фармацевтика Н.В. Pyridine derivatives used as quickly dissociable dopamine receptor 2 antagonists
KR101506156B1 (en) 2007-04-23 2015-03-26 얀센 파마슈티카 엔.브이. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
AU2008240728B2 (en) 2007-04-23 2013-01-10 Janssen Pharmaceutica N.V. 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
BRPI0915834A2 (en) 2008-07-03 2015-11-03 Janssen Pharmaceutica Nv Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists
DK2307374T3 (en) 2008-07-31 2017-05-01 Janssen Pharmaceutica Nv PIPERAZIN-1-YLTRIFLUORMETHYL-SUBSTITUTED PYRIDINES AS QUICK DISSOCATING DOPAMIN-2 RECEPTOR ANTAGONISTS

Also Published As

Publication number Publication date
DE2642856C2 (en) 1990-06-21
DK427876A (en) 1977-03-24
CH628623A5 (en) 1982-03-15
PH12497A (en) 1979-04-05
FI61482C (en) 1982-08-10
AU510029B2 (en) 1980-06-05
IT1073893B (en) 1985-04-17
DE2642856A1 (en) 1977-03-24
NO147672C (en) 1983-05-25
CS222663B2 (en) 1983-07-29
SE7610501L (en) 1977-03-24
PT65631B (en) 1978-07-05
PT65631A (en) 1976-10-01
ES451768A1 (en) 1978-05-01
NL187267B (en) 1991-03-01
YU233676A (en) 1983-01-21
FI762698A (en) 1977-03-24
PL192578A1 (en) 1979-02-26
NZ181972A (en) 1978-07-28
GB1539473A (en) 1979-01-31
NL7610513A (en) 1977-03-25
SE427839B (en) 1983-05-09
FI61482B (en) 1982-04-30
DK150478B (en) 1987-03-09
GR58469B (en) 1977-10-14
RO70079A (en) 1982-10-26
FR2325377A1 (en) 1977-04-22
JPS6016417B2 (en) 1985-04-25
SU747424A3 (en) 1980-07-23
ATA702976A (en) 1981-02-15
LU75837A1 (en) 1977-05-04
IL50522A0 (en) 1976-11-30
FR2325377B1 (en) 1980-04-18
DK150478C (en) 1987-10-05
IE43802B1 (en) 1981-06-03
PL117323B1 (en) 1981-07-31
AT363935B (en) 1981-09-10
NO147672B (en) 1983-02-14
JPS5239683A (en) 1977-03-28
BG27543A3 (en) 1979-11-12
IL50522A (en) 1979-09-30
HU172964B (en) 1979-01-28
AU1787876A (en) 1978-03-23
YU39973B (en) 1985-06-30
IE43802L (en) 1977-03-23
CA1068271A (en) 1979-12-18
NO763054L (en) 1977-03-24

Similar Documents

Publication Publication Date Title
NL186694C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION, PROCESS FOR PREPARING 2 (1H) -PYRIDINONES, AND FORMED PREPARATION.
NL7605635A (en) PROCESS FOR PREPARING A POLYAMINE.
NL7611635A (en) PROCESS FOR PREPARING A MODIFIED POLYSACCHARIDE.
NL178688C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION AS A MUSCLE RELAXAN AND SUITABLE BIS-ISOQUINOLINIUM COMPOUNDS.
NL190313C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH RETARD EFFECT.
NL7607902A (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION.
NL7606172A (en) PROCESS FOR PREPARING N-SUBSTITUTED 2-METHOXYBENZE SULPHONAMIDES, PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION USING THIS AS WELL AS A PREPARATION SUCHED.
NL184558C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION CONTAINING A MOTHERNESS CALCALIDE; PHARMACEUTICAL OBJECT.
NL7607011A (en) METHOD FOR PREPARING BICYCLOHEPEN COMPOUNDS, METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION USING THEREOF AND AN SUCH PREPARATION.
NL7606824A (en) PROCESS FOR PREPARING AN ORAL PREPARATION.
NL187267C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION, AND PROCESS FOR PREPARING AN N-ARYL-N- (4-PIPERIDINYL) ACETAMIDE DERIVATIVE.
NL7604777A (en) PROCESS FOR PREPARING A TISSUE-FRESHING PREPARATION.
NL7605322A (en) PROCESS FOR PREPARING A THERAPEUTIC PREPARATION.
NL163780B (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION, PRODUCED PREPARED PREPARATION THEREOF, AND METHOD
NL187166C (en) PROCESS FOR PREPARING A 7-ACYLAMINO-3-ACYLOXYMETHYL-3-CEFEM-4-CARBONIC ACID DERIVATIVE, AND METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTIBACTERIAL ACTION.
NL7706619A (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION.
NL7606284A (en) SUBSTITUTED BENZAMIDES, DERIVATIVES THEREOF, PROCESS FOR PREPARING SUBSTITUTED BENZAMIDES AND DERIVATIVES THEREOF, PROCEDURE FOR PREPARING PHARMACOLOGICAL PREPARATIONS AND PREPARATIONS.
NL168214C (en) PROCESS FOR PREPARING A BETA-DIHALOGENETHENYLCYCLOPROPANIC CARBONIC ACID DERIVATIVE.
NL7613664A (en) ODOR-DISPOSING PRODUCTS AND A METHOD FOR PREPARING SUCH PRODUCTS
NL176270C (en) METHOD FOR PREPARING AN AMORF, SOLID MACROLIDE ANTIBIOTIC, AND A MEDICINAL PRODUCT THEREOF
NL7609793A (en) ARALKYLAMIDES OF AMINO ACIDS, A PHARMACEUTICAL PREPARATION, AND METHODS FOR PREPARING THEM.
NL174346C (en) PROCESS FOR PREPARING A 1,3-DIARYLTRIAZENE.
NL188982C (en) PROCESS FOR PREPARING A VACCINE AGAINST HEPATITIS A.
NL7602087A (en) METHOD FOR PREPARING A COPOLYMER.
NL7600045A (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 960922